Berry Global Announces Investment to Address Ongoing Wipes Shortage

Berry Global Group, Inc. (NYSE: BERY), a leading global nonwovens manufacturer, announced its investment of over $70 million in its United States wipe substrate capabilities. The investment includes a new line, producing additional capacity, and enabling the Company to better serve its global customers as well as support the continuing growth of its business. Berry provides many of the world’s leading brands with wipe materials for infection prevention. Prior to the demand surge of 2020, the impregnated wet wipes segment, specific for home cleaning and disinfecting, was growing at six percent in the 2014 to 2019 time frame. Amplified by COVID-19 prevention, the demand for disinfectant wipes is expected to have permanently shifted to its current, increased use.

Berry will add to its broad scope and scale by installing the line in the United States. This investment is complementary to Berry’s existing portfolio and features the Company’s proprietary Spinlace® technology. The U.S. investment has a targeted commercialization date of the March quarter 2023.

“This investment reflects the commitment we have in support of our customers’ growth plans and it is a clear signal of our intent to provide the best products in the disinfectant wiping space worldwide,” said Mark Siebert, EVP and General Manager, U.S. and Canada, Healthcare and Specialties at Berry.

Berry’s Spinlace® technology is a critical component of its growth in the wiping space, as it enables the Company to produce and deliver innovative nonwovens to customers across multiple market segments. These segments include home care, personal care, commercial, transportation, and healthcare. The newly announced asset will be flexible in its production capabilities, with the ability to supply materials for wipes, filtration, personal care incontinence, and healthcare applications.

Berry continues to differentiate itself in the market with its unmatched expertise and technologies. The Company’s Spinlace® technology is a highly efficient process that incorporates almost limitless material inputs, including pulp, with high-speed hydroentanglement. Additionally, Berry’s proprietary Apex™ technology is combined with Spinlace® technology to impart customizable three-dimensional images directly into the fabric to provide differentiated functional and aesthetic attributes. The Apex® process improves strength, pick up or lay down of liquids, and improves visuals versus traditional manufacturing methods.

Berry holds a unique position in the nonwovens market with its ability to serve such a broad range of customers and technologies. The Company continues to reinvest and innovate in the nonwovens space, enabling efficient production of quality materials and furthering its leadership role in the industry.
https://ir.berryglobal.com/news-releases/news-release-details/berry-global-announces-investment-address-ongoing-wipes-shortage

Related Posts

Huhtamaki launches Push Tab® blister lid, a first-to-market, aluminum-free, mono-material PET blister lidding, for the global healthcare industry

Huhtamaki, a key global provider of sustainable packaging solutions, announces a first-to-market sustainable innovation for the global pharmaceutical and healthcare industry. Huhtamaki's Push Tab® blister lid is mono-material PET and free from aluminum. It is designed to meet the stringent safety requirements of highly regulated pharmaceutical and healthcare packaging and provides the industry with a more sustainable alternative to traditional push-through blister packaging. This game changing innovation will help deliver sustainable packaging solutions for the growing global healthcare industry, whilst importantly maintaining functionality and efficiency, as Push Tab® blister lid runs on existing blister packaging lines without compromising on speed. The Huhtamaki Push Tab® blister lid is made of mono-material PET (polyethylene terephthalate) which significantly improves recyclability of the packaging, whilst remaining compatible with existing high performance blister packaging lines, without needing modifications or extra investment. Huhtamaki and its partner – Klöckner Pentaplast – bring this first-to-market innovation to help the global healthcare and pharmaceutical sector meet their sustainability targets and achieve market growth at the same time. In 2021, European packaging sales in the healthcare category had an estimated value of EUR 1.4 billion, of which approximately 50% were in blister packaging.

ePac Flexible Packaging Announces Expansion into Poland

ePac Flexible Packaging is pleased to announce its third European facility, ePac Poland North, located near the cities of Poznan and Bydgoszcz. This expands ePac’s network of sales and production operations across the Continent, builds on the successful launch of European sites in the UK (Silverstone) and France (Lyon), and further signals the company’s intent to become the supplier of choice in local markets throughout Europe. ePac Poland North is a partnership between ePac and mFlex, and will operate from mFlex’s production facility, an established flexible packaging facility that already uses digital printing. The company will be led by Managing Partners Jacek Ciosek and Marcin Kowalski; both seasoned executives in flexible packaging who will manage ePac’s operations and customer relationships.

A decade of more sustainable choices: Celebrating 10 years of UPM Raflatac’s Label Life service

Label Life by UPM Raflatac proudly marks 10 years of its life cycle assessment service. Over the past decade, Label Life has been a comprehensive life cycle assessment tool for label evaluation, enabling businesses to make informed, environmentally responsible decisions. Continuously evolving to cover an ever-widening portfolio of more sustainable products, Label Life now accounts for over 90% of UPM Raflatac’s commercial portfolio by sales volume, reflecting the company’s commitment to sustainability. Label Life provides essential environmental information on label materials, utilizing the standardized method of life cycle assessment (LCA) to calculate their environmental impact from cradle-to-grave. Customers benefit from individual footprints or “product passport prototypes” (PPPs) displaying 25 indicators, as well as focused comparisons of three key metrics—greenhouse gas emissions, energy demand, and water consumption—facilitating a transparent and guided decision-making process.
Back To Top
×Close search
Search